oxazoles has been researched along with Bowel Diseases, Inflammatory in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (50.00) | 2.80 |
Authors | Studies |
---|---|
Alfonsi, D; Cordaro, M; Crupi, R; Cuzzocrea, S; D'amico, R; Di Paola, R; Evangelista, M; Filippo Peritore, A; Fusco, R; Gugliandolo, E; Impellizzeri, D; Marcolongo, G; Mattei, N; Pozzebon, M; Scuto, M; Siracusa, R | 1 |
Albert, LM; Frail, DE; Harris, HA; Henderson, RA; Keith, JC; Kharode, YP; Komm, BS; Leathurby, Y; Malamas, MS; Marzolf, J; Mewshaw, RE; Miller, CP; Winneker, RC; Zhu, Y | 1 |
2 other study(ies) available for oxazoles and Bowel Diseases, Inflammatory
Article | Year |
---|---|
Effect of N-palmitoylethanolamine-oxazoline on comorbid neuropsychiatric disturbance associated with inflammatory bowel disease.
Topics: Amides; Animals; Body Weight; Calcium-Binding Proteins; Dextran Sulfate; Ethanolamines; Glial Cell Line-Derived Neurotrophic Factor; Glial Fibrillary Acidic Protein; Humans; Immunohistochemistry; Inflammatory Bowel Diseases; Intercellular Adhesion Molecule-1; Male; Microfilament Proteins; Oxazoles; P-Selectin; Palmitic Acids; Rats; Rats, Sprague-Dawley | 2020 |
Evaluation of an estrogen receptor-beta agonist in animal models of human disease.
Topics: Animals; Animals, Genetically Modified; Arthritis, Experimental; beta 2-Microglobulin; Bone Density; Bone Diseases, Metabolic; Cell Line; Disease Models, Animal; Estrogen Receptor beta; Female; HLA-B27 Antigen; Humans; Inflammatory Bowel Diseases; Mammary Glands, Animal; Mice; Ovariectomy; Oxazoles; Rats; Rats, Inbred Lew; Rats, Sprague-Dawley; Receptors, Estrogen; Uterus; Weight Gain | 2003 |